Cell therapies are a hot topic in the bio/pharma industry today. In this episode, Meg Rivers, senior editor, Andrew Scharenberg, CEO, Umoja Biopharma, and Ryan Crisman, co-founder and chief technical officer, Umoja Biopharma, discuss 1) the greatest advancements in cell therapy to date; 2) where there’s room for improvement; 3) the biggest trends in cell therapy development; 4) the pros and cons of developing cell and gene therapies; 5) the challenges related to retention, 6) scale up vs. scale out; and 7) various challenges and opportunities for autologous and allogeneic therapies. SPONSORS: Curia, Samsung Biologics